Company · CIK 2002988

# Retension Pharmaceuticals, Inc.

| CIK | [2002988](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0002002988) (SEC EDGAR) |
| --- | --- |
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | VA |
| Listed | RTSN (Nasdaq) |
| First annual or quarterly report | none on EDGAR |

## Offerings

 1 registration

| Registration | Label and status | First filed | Last event | Filings |
| --- | --- | --- | --- | --- |
| 333-299024 | IPO Final prospectus | 2026-09-18 | 2026-10-09 | 5 |

## Filings

 6

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2026-10-09 | [424B4](https://www.sec.gov/Archives/edgar/data/2002988/000121390026108587/0001213900-26-108587-index.htm) Final prospectus | 333-299024 | 0001213900-26-108587 |
| 2026-10-08 | [EFFECT](https://www.sec.gov/Archives/edgar/data/2002988/999999999526003189/9999999995-26-003189-index.htm) Declared effective | 333-299024 | 9999999995-26-003189 |
| 2026-10-07 | [S-1/A](https://www.sec.gov/Archives/edgar/data/2002988/000121390026107572/0001213900-26-107572-index.htm) Amendment | 333-299024 | 0001213900-26-107572 |
| 2026-10-05 | [S-1/A](https://www.sec.gov/Archives/edgar/data/2002988/000121390026106636/0001213900-26-106636-index.htm) Amendment | 333-299024 | 0001213900-26-106636 |
| 2026-09-18 | [S-1](https://www.sec.gov/Archives/edgar/data/2002988/000121390026101499/0001213900-26-101499-index.htm) Registration filed | 333-299024 | 0001213900-26-101499 |
| 2026-02-17 | [DRS](https://www.sec.gov/Archives/edgar/data/2002988/000121390026017320/0001213900-26-017320-index.htm) Draft made public | 377-09081 | 0001213900-26-017320 |

[All filings of this company](https://equitycapital.markets/filings?cik=2002988) · [CSV](https://equitycapital.markets/filings.csv?cik=2002988)

---
Source page: https://equitycapital.markets/company/2002988 · Data: U.S. SEC EDGAR · CC BY 4.0